B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Cd11b Antigen

56 PubMed studies analyzed ยท 1 RCTs ยท Evidence Score: 42.7

Research Domains

Cd11b Antigen has been studied across 15 research domains including ๐Ÿ”ฌ Oncology, ๐Ÿ›ก๏ธ Immunity, ๐Ÿ”ฌ Inflammation, ๐Ÿฆด Bone & Joint, ๐Ÿ‘๏ธ Vision & Eye. The primary research focus is ๐Ÿ”ฌ Oncology with 45% of studies addressing this area.

Loading evidence profile...

This evidence profile for Cd11b Antigen is generated deterministically from 56 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.